UPDATED Nov. 20, 2015, with comment from Mindray. Masimo (NSDQ:MASI) said today that it agreed to settle its legal beef with Mindray (NYSE:MR) for $25 million. The settlement ends a bevy of legal proceedings in the U.S. and China, where Mindray is based. Masimo 1st sued Mindray in December 2012 in a California federal court, alleging patent infringement and breach […]
Anti-Trust
Steris, Synergy delay shareholder votes ahead of anti-trust ruling on $2B merger
Steris (NYSE:STE) and Synergy Health postponed their shareholders meetings to give a U.S. court time to rule on the Federal Trade Commission’s bid to halt their $1.9 billion merger. Mentor, Ohio-based Steris said it moved its meeting from Sept. 24 to Oct. 2; Synergy plans to hold its vote the same day, according to a regulatory filing. Earlier […]
FTC: We might force M&A divestitures in outside markets
The U.S. Federal Trade Commission last week said it may force companies to divest assets outside of the market the anti-monopoly bureau its trying to regulate.
Supremes deny BD bid for appeal in Retractable Technologies case
Cardinal Health to pay $27m to settle FTC anti-trust charges
Zimmer extends deadline for $13B Biomet deal
European regulators OK $13B Zimmer-Biomet deal
Japan OKs $13B Zimmer-Biomet merger
Distributor 3B Medical levels anti-trust lawsuit against ResMed
U.K. regulators pass on probe of Zoll Medical’s Philips InnerCool buy
BD notches partial win in $352m anti-trust loss to Retractable Technologies
